Respiratory Burst Activity in MDS MPS Patients (original) (raw)

Ras activation in myelodysplastic syndromes: clinical and molecular study of the chronic phase of the disease

British journal of …, 1990

Deficiency of neutrophilic granule membrane glycoproteins in the myelodysplastic syndromes: A common deficiency in 216 patients studied by the cancer and leukemia group B

Bercedis Peterson

Leukemia Research, 1997

View PDFchevron_right

P-138 New approaches for risk assessment of patients with myelodysplastic syndrome

Liana Gercheva

Leukemia Research, 2013

View PDFchevron_right

Coregulation of NADPH oxidase activation and phosphorylation of a 48-kD protein(s) by a cytosolic factor defective in autosomal recessive chronic granulomatous disease

Charles McCall

Journal of Clinical Investigation, 1988

View PDFchevron_right

P063 DNA damage in peripheral blood cells of MDS patients

Evangelos Tzolos, A. Symeonidis

Leukemia Research, 2009

View PDFchevron_right

Expression and functional analysis of granulocyte colony-stimulating factor receptors on CD34++ cells in patients with myelodysplastic syndrome (MDS) and MDS-acute myeloid leukaemia

Tanvira Afroze

British Journal of Haematology, 2003

View PDFchevron_right

Myelodysplastic syndrome patients present more severe respiratory muscle impairment and reduced forced vital capacity: Is disordered inflammatory signaling the culprit?

Roberta Oliveira

PLOS ONE, 2017

View PDFchevron_right

A standardized blood test for the routine clinical diagnosis of impaired GM-CSF signaling using flow cytometry

Bruce Trapnell

Journal of immunological methods, 2014

View PDFchevron_right

Myelodysplastic syndromes: recent advances

Enrica Morra

Haematologica, 2001

View PDFchevron_right

Determination of Ras-GTP and Ras-GDP in patients with acute myelogenous leukemia (AML), myeloproliferative syndrome (MPS), juvenile myelomonocytic leukemia (JMML), acute lymphocytic leukemia (ALL), and malignant lymphoma: assessment of mutational and indirect activation

Tomasz Zemojtel

Annals of Hematology, 2009

View PDFchevron_right

Altered surface expression of effector cell molecules on neutrophils in myelodysplastic syndromes

Isao Nagaoka

British Journal of Haematology, 1997

View PDFchevron_right

The role of integrins in granulocyte dysfunction in myelodysplastic syndrome

Iolanda Mazzucchelli

Leukemia Research, 1993

View PDFchevron_right

Flow cytometry immunophenotyping for diagnosis of myelodysplastic syndrome

Fabiana Mello

Haematologica, 2009

View PDFchevron_right

The Role of Flow Cytometry in the Diagnosis of Myelodysplasic Syndromes

Nazim Bennaoum

Journal of Hematology & Thromboembolic Diseases, 2013

View PDFchevron_right

PKR is activated in MDS patients and its subcellular localization depends on disease severity

C. Bosi, William Blalock

Leukemia, 2008

View PDFchevron_right

ELEVATED RED CELL ADENOSINE DEAMINASE AND HAEMOLYSIS IN A PATIENT WITH A MYELODYSPLASTIC SYNDROME

Eng Gan

British Journal of Haematology, 1989

View PDFchevron_right

Effects of myeloid cell growth factors on alkaline phosphatase, myeloperoxidase, defensin and granulocyte colony-stimulating factor receptor mRNA expression in haemopoietic cells of normal individuals and myeloid disorders

Satoshi Takahashi

British Journal of Haematology, 1996

View PDFchevron_right

Mutation in RAP1 is a rare event in myelodysplastic syndromes

Catherine Lacombe

Leukemia, 2005

View PDFchevron_right

Effects of prolonged treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor

Tim Donlon

The International Journal of Cell Cloning, 2000

View PDFchevron_right

Symposium 12: New molecular biology techniques in clinical biochemistry

G. Monni

Fresenius' Journal of Analytical Chemistry, 1990

View PDFchevron_right

Clinical and Cytometric Study of Immune Involvement in a Heterogeneous Cohort of Subjects With RASopathies and mTORopathies

Andrea Magnolato

Frontiers in Pediatrics, 2021

View PDFchevron_right

The role of flow cytometry examination in the diagnosis and prognosis of myelodysplastic syndromes

Zsuzsanna Hevessy

2018

View PDFchevron_right

Glycosyl-phosphatidyl-inositol-defective granulocytes from paroxysmal nocturnal haemoglobinuria patients show increased bacterial ingestion but reduced respiratory burst induction

Fiorella Alfinito

American Journal of Hematology, 2007

View PDFchevron_right

PYGM expression analysis in white blood cells: A complementary tool for diagnosing McArdle disease?

Astrid Brull

Neuromuscular Disorders, 2014

View PDFchevron_right

Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes

Aristoteles Giagounidis

British Journal of Haematology, 2009

View PDFchevron_right

Myelodysplastic Syndromes: What a Primary Care Physician Needs to Know

Awais khan

Dm Disease-a-month, 2010

View PDFchevron_right

Genetics factors associated with myelodysplastic syndromes

Josiane Alencar, Ana Silvestre, Joana Zacarias, Ana Sell, Jeane Visentainer

Blood Cells, Molecules, and Diseases, 2015

View PDFchevron_right

Peripheral blood MDS score: A new flow cytometric tool for the diagnosis of myelodysplastic syndromes

Jonni Moore

Cytometry Part B: Clinical Cytometry, 2005

View PDFchevron_right

Issues in the Pathology of the Myelodysplastic Syndromes

PATRICIA KAMPMEIER, MD

Hematology/Oncology Clinics of North America, 1992

View PDFchevron_right

Leukemic transformation in patients with myelodysplastic syndromes after treatment with granulocyte colony-stimulating factor

Sotirios Sachanas

Leukemia & Lymphoma, 2012

View PDFchevron_right

Respiratory Burst Activity in MDS MPS Patients (original) (raw)

Related papers